Molecular identification of Epstein-Barr virus in human placental tissue

Amer Nubgan

Abstract


Background: The Epstein-Barr virus (EBV) relates to the torch virus family and is believed to have a substantial impact on mortality and perinatal events, as shown by epidemiological and viral studies. Moreover, there have been documented cases of EBV transmission occurring via the placenta. Nevertheless, the specific location of the EBV infection inside the placenta remains uncertain.

Methods: The genomic sequences connected to the latent EBV gene and the levels of lytic EBV gene expression in placental chorionic villous cells are examined in this work. A total of 86 placentas from patients who had miscarriage and 54 placentas from individuals who had successful births were obtained for analysis.

Results: The research employed QPCR to detect the BRLF1 (Rta) EBV lytic gene and quantify DNA burden in miscarriage patients and controls. In miscarriage patients, endpoint PCR and Sanger sequencing validated a particular region of the EBER1 EBV latent gene. BRLF1 gene presence ranged from 2.5 × 102 to 9.3 × 104 copies/mL in 75 miscarriage patients. However, a sample of 5 people with healthy deliveries showed a range of 2.0 × 102 to 2.9 × 102 copies/mL. All miscarriage samples were observed EBER1. The sequencing results indicated full sequence identity to EBV strains.

Conclusion:The detection of EBV gene expression in placental tissues in Iraq is a novel finding. The examination of EBV is of utmost importance in pregnant women who are experiencing severe illness, since it has the potential to lead to mortality in both the mother and the developing fetus.

 


Full Text:

PDF

References


Avgil M, Ornoy A. Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection. Reproductive Toxicology, (2006); 21(4): 436–445.

W. Ahmed D. Effects of Interleukin-2 (IL-2) and Interleukin-6 (IL-6) in Recurrent Spontaneous Abortion (RSA). Iraqi Journal of Pharmaceutical Sciences, (2017); 17(2): 74–79.

Chang MS, Lee HS, Kim CW, Kim Y Il, Kim WH. Clinicopathologic Characteristics of Epstein-Barr Virus-Incorporated Gastric Cancers in Korea. Pathology - Research and Practice, (2001); 197(6): 395–400.

Fleisher G, Henle W, Henle G, Lennette ET, Biggar RJ. Primary Infection with Epstein-Barr Virus in Infants in the United States: Clinical and Serologic Observations. Journal of Infectious Diseases, (1979); 139(5): 553–558.

Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus. Nature Medicine, (2002); 8(6): 594–599.

Lafta FM, AL-Jumaily RMK, Rasoul LM. Global DNA Methylation Levels in Epstein-Barr-Virus-Positive Iraqi Patients with Acute Lymphoblastic Leukaemia. Iraqi Journal of Science, (2023); 64(3) : 1109–1118.

Draborg AH, Duus K, Houen G. Epstein-Barr Virus in Systemic Autoimmune Diseases. Clinical and Developmental Immunology, (2013); 2013: 535738.

Mousa Al-Mousawi HT, AL-Hajjar QN. Immunological and Molecular Diagnosis of Cytomegalovirus Infection between Aborted & Pregnant Women in Babylon City. Baghdad Science Journal, (2021); 18(2): 1086.

Ali SHM, Mohammed KIA, Ali WM, AL-Fakhar SA, Al-Alwany SHM, Mousa JM. In Situ Hybridization for Molecular Detection of Human Papilloma Viral 6 / 11 DNA in Adenoctomized Tissues from A group of Iraqi Pediatric Patients. Baghdad Science Journal, (2022); 19(1): 0026.

Okano M, Gross TG. Acute or Chronic Life-Threatening Diseases Associated With Epstein-Barr Virus Infection. The American Journal of the Medical Sciences, (2012); 343(6): 483–489.

Hui KF, Chan TF, Yang W, Shen JJ, Lam KP, et al. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma. International Journal of Cancer, (2018); 2(144): 3031–3042.

Yap LF, Wong AKC, Paterson IC, Young LS. Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis. Cancers, (2022); 14(23): 5780.

Swaminathan S. Noncoding RNAs produced by oncogenic human herpesviruses. Journal of Cellular Physiology, (2008); 216(2): 321–326.

Hwang SP, Huang LC, Wang WH, Lin MH, Kuo CW, et al. Expression of Rta in B Lymphocytes during Epstein–Barr Virus Latency. Journal of Molecular Biology, (2020); 432(19): 5227–5243.

Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell, (1994); 77(6): 791–793.

Turkey EF, Hamad AG, AL-Mansoori AK. The Association of Prothrombin Gene Mutations and Cytomegalovirus Infection with Abortion Among Iraqi Women. Baghdad Science Journal, (2022); 19(4): 0768.

Song B, Liu JJ, Yeh K-C, Knipe DM. Herpes Simplex Virus Infection Blocks Events in the G1 Phase of the Cell Cycle. Virology, (2000); 267(2): 326–334.

Ehmann GL, McLean TI, Bachenheimer SL. Herpes Simplex Virus Type 1 Infection Imposes a G1/S Block in Asynchronously Growing Cells and Prevents G1 Entry in Quiescent Cells. Virology, (2000); 267(2): 335–349.

Tiwari D, Mittal N, Jha HC. Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation. Current Research in Neurobiology, (2022); 30(3): 100046.

Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ. Strain Variation in Epstein-Barr Virus Immediate Early Genes. Virology, (1993); 192(2): 541–550.

Zhang JB, Huang SY, Wang TM, Dong SQ, He YQ, et al. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma. EBioMedicine, (2018); 37: 101–109.

Darr CD, Mauser A, Kenney S. Epstein-Barr Virus Immediate-Early Protein BRLF1 Induces the Lytic Form of Viral Replication through a Mechanism Involving Phosphatidylinositol-3 Kinase Activation. Journal of Virology, (2001); 75(13): 6135–6142.

Liu C, Sista ND, Pagano JS. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. Journal of Virology, (1996); 70(4): 2545–2555.

Myers JE, Schaal DL, Nkadi EH, Ward BJH, Bienkowska-Haba M, Sapp M, Bodily JM, Scott RS. Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia. Banks L, ed. Journal of Virology, (2023); 97(2): e0103222

Ragoczy T, Heston L, Miller G. The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes. Journal of Virology, (1998); 72(10): 7978–7984.

Heilmann AMF, Calderwood MA, Portal D, Lu Y, Johannsen E. Genome-Wide Analysis of Epstein-Barr Virus Rta DNA Binding. Journal of Virology, (2012); 86(9): 5151–5164.

Ho JWY, Li L, Wong KY, Srivastava G, Tao Q. Comprehensive Profiling of EBV Gene Expression and Promoter Methylation Reveals Latency II Viral Infection and Sporadic Abortive Lytic Activation in Peripheral T-Cell Lymphomas. Viruses, (2023); 15(2): 423.

Abbas MD, Egbe SS. Seroprevalence of CMV in Women with Bad Obstetric History in Babil/Iraq. Iraqi Journal of Pharmaceutical Sciences, (2021); 30(2): 106–112.

Chen WG, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt’s lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. The American journal of pathology, (1996); 148(1): 17–23.

Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. The Epstein--Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. Journal of General Virology, (1991); 72(7): 1579–1590.

Wang HY, Sun L, Li P, Liu W, Zhang ZG, Luo B. Sequence Variations of Epstein-Barr Virus-Encoded Small Noncoding RNA and Latent Membrane Protein 1 in Hematologic Tumors in Northern China. Intervirology, (2021); 64(2): 69–80.

Zhu P, Chen YJ, Hao JH, Ge JF, Huang K, et al. Maternal depressive symptoms related to Epstein-Barr virus reactivation in late pregnancy. Scientific Reports, (2013); 3(1): 3096.

Elliott SE, Parchim NF, Kellems RE, Xia Y, Soffici AR, Daugherty PS. A pre-eclampsia-associated Epstein-Barr virus antibody cross-reacts with placental GPR50. Clinical Immunology, (2016); 168: 64–71.

Tomai X. Stillbirth following severe symmetric fetal growth restriction due to reactivation of Epstein–Barr virus infection in pregnancy. Journal of Obstetrics and Gynaecology Research, (2011); 37(12): 1877–1882.

Long X, Yang J, Zhang X, Yang Z, Li Y, Wang F, Li X, Kuang E. BRLF1 suppresses RNA Pol III‐mediated RIG‐I inflammasome activation in the early EBV lytic lifecycle. EMBO reports, (2021); 22(1): e50714.

Nubgan A. The deubiquitylase-ubiquitin-specific protease 4 absence in HeLa cells leads to a reduction in Semliki Forest virus replication. Human Gene, Elsevier, (2023);

: 201170.

Hakim H, Gibson C, Pan J, Srivastava K, Gu Z, Bankowski MJ, Hayden RT. Comparison of Various Blood Compartments and Reporting Units for the Detection and Quantification of Epstein-Barr Virus in Peripheral Blood. Journal of Clinical Microbiology, (2007); 45(7): 2151–2155.

Saleh DS, Kharibet KE. Detection of Cytomegalovirus, Rubella virus, and IL-2 Levels in a Sample of Recurrently Aborted Iraqi Women. Iraqi Journal of Science, (2015); 56(3A): 1890–1894.

Zekri ARN, Bahnassy AA, Mohamed WS, El-Kassem FA, El-Khalidi SJ, et al. Epstein-Barr virus and breast cancer: Epidemiological and Molecular study on Egyptian and Iraqi women. Journal of the Egyptian National Cancer Institute, (2012); 24(3): 123–131.

Wang Y, Rong Y, Yang L, Lu Z. Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines. Virus Genes, (2023); 59(4): 541–553.

Abd Al Kareem RM, Abd WS. Impact of EBV on Multiple in a Sample of Iraqi Females: Immunological and Molecular Study. Iraqi Journal of Science, (2020); 61(5): 1008–1015.

Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. Journal of Clinical Microbiology, (1997); 35(6): 1612–1615.

Van Esser JWJ, Niesters HGM, Thijsen SFT, Meijer E, Osterhaus ADME, et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic stem cell transplantation. British Journal of Haematology, (2001); 113(3): 814–821.

Chan KCA, Zhang J, Chan ATC, Lei KIK, Leung SF, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer research, (2003); 63(9): 2028–32.

Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma. New England Journal of Medicine, (2004); 350(24): 2461–2470.

Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. Journal of Clinical Microbiology, (1995); 33(7): 1765–1768.

Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, et al. Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay. Journal of Clinical Microbiology, (1999); 37(1): 132–136.

Stevens SJC, Blank BSN, Smits PHM, Meenhorst PL, Middeldorp JM. High Epstein–Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS, (2002); 16(7): 993–1001.

Stevens SJC, Pronk I, Middeldorp JM. Toward Standardization of Epstein-Barr Virus DNA Load Monitoring: Unfractionated Whole Blood as Preferred Clinical Specimen. Journal of Clinical Microbiology, (2001); 39(4): 1211–1216.

Ad’hiah AH, Atiyah NS, Fadhil HY. Qualitative and Quantitative Molecular Analysis of Epstein-Barr Virus in Iraqi Patients with Relapsing-Remitting Multiple Sclerosis. Iraqi Journal of Science, (2023); 64(1): 127–137.




DOI: http://dx.doi.org/10.62940/als.v10i4.2964

Refbacks

  • There are currently no refbacks.